ArticleCureus2026
Platelet Function Disorders: Glanzmann Thrombasthenia and Type 2 Von Willebrand Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bleeding disorders represent a broad spectrum of conditions that disrupt normal clot formation through abnormalities in platelet function or the coagulation cascade. Disorders affecting primary hemostasis typically manifest as mucosal bleeding, whereas abnormalities in secondary hemostasis more often lead to deep tissue hemorrhage. However, certain conditions, such as von Willebrand disease, may involve features of both pathways, complicating clinical evaluation. This report describes two adolescent patients who presented with mucocutaneous bleeding but were ultimately diagnosed with different underlying conditions: Glanzmann thrombasthenia and type 2 von Willebrand disease. The first patient exhibited recurrent gingival bleeding with normal platelet counts and near-normal coagulation studies. Further evaluation using platelet aggregation testing revealed impaired responses to multiple agonists, consistent with a defect in platelet aggregation. The second patient presented with gingival bleeding and severe menorrhagia and was initially treated as a case of hemophilia due to reduced factor VIII levels. Lack of therapeutic response prompted further testing, which demonstrated abnormal von Willebrand factor activity, confirming a qualitative defect. These cases highlight the importance of correlating clinical presentation with specialized laboratory investigations. Reliance on routine tests alone may lead to misdiagnosis, whereas a systematic diagnostic approach allows accurate identification and appropriate management of bleeding disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.